Azuma Arata

Savoirs

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts

Azuma Arata, Usuki Jiro, Abe Shinji, Matsuda Kuniko, Sunazuka Toshiaki, Shimizu Takako, Hirata Yukiyo, Inagaki Hirofumi, Kawada Tomoyuki, Takahashi Satoru, Kudoh Shoji, Omura Satoshi, Li

Savoirs

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial

Taniguchi Hiroyuki, Kondoh Yasuhiro, Ebina Masahito, Azuma Arata, Ogura Takashi, Taguchi Yoshio, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Sugiyama Yukihiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone

Savoirs

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Azuma Arata, Taguchi Yoshio, Ogura Takashi, Ebina Masahito, Taniguchi Hiroyuki, Kondoh Yasuhiro, Suga Moritaka, Takahashi Hiroki, Nakata Koichiro, Sato Atsuhiko, Kudoh Shoji, Nukiwa Toshihiro, Pirfenidone